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Treatment of amino-group-containing antigens with adenosine-5 ’ -trimetaphosphate results in their 
chemical modification by -pppA residues. An immunoanalytical system is proposed based upon 
competition of these ATP-labelled antigens with those of the sample for immobilized antibodies. Mild 
acidic treatment of complexes of ATP-labelled antigens with immobilized antibodies results in quantitative 
liberation of intact ATP. The latter may be determined by the ultrosensitive bioluminescent techniques 
based upon emission of light with firefly luciferase. The validity of the system has been studied with two 
clinically important antigens, thyroxine and myoglobin. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Much effort is put into elaboration of novel im- 
munoanalytical systems alternative to radioimmu- 
noanalysis. Enzymes, fluorescent and chemilumin- 
escent compounds and free radicals are used as 
alternative labels [l]. The high sensitivity and the 
simplicity of the well-known luciferin-iuciferase 
test [2] make ATP an attractive alternative label 
for immunoanalysis. ATP-metric immunoanalyti- 
cal procedures have been proposed in [3,4]. Ac- 
cording to these procedures, ATP-labelled an- 
tigens themselves are taken into the luciferin-luci- 
ferase reaction. However, the presence of antigens 
as substituents at position 6 of the adenosine 
residue of ATP leads to a considerable and un- 
predictable decrease of the substrate activity of 
these derivatives compared with ATP, and conse- 
quently to a decrease in the sensitivity of the assay. 
2.1. Synthesis of adenosine-5 ‘-trimetaphosphate 
(A TMP) 
This was done as in [5]: 40 mg dry triethylam- 
monium ATP was dissolved in 400 ,uI dry dime- 
thylsulfoxide; 120 mg dicyclohexylcarbodiimide 
and 4 mg pyridinium hydrochloride were added, 
and the mixture kept for 1 h at 25°C. The yield of 
ATMP as determined in [5] was 100%. Dicyclo- 
hexylurea was removed by decantation. The dime- 
thylsulfoxide solution of ATMP thus obtained was 
stored at - 10°C. 
2.2. The synthesis of the ATP y-amide, the 
derivative of thyroxine methyl ester 
(Me Td-A TP) 
Here, we describe a novel ATP-metric immu- 
noanalytical system, the most important feature of 
which is liberation of intact ATP from the complex 
of the ATP-labelled antigen with antibodies. 
Thyroxine and myoglobin were taken as model 
antigens. 
Thyroxine methyl ester (MeTA) was obtained as 
in [6]. The structure of the compound was deter- 
mined by PMR-spectroscopy: 20 mg MeT4 - HCI 
was dissolved in 500~1 dry methanol; 100~1 dry 
triethylamine was added, followed by 100,~l 
ATMP dimethylsulfoxide solution (section 2.1). 
The mixture was kept for 30 min at 37°C and 
poured into 40 ml water. The solution was applied 
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to a DEAE-cellulose column, and chromatography 
was performed in a linear gradient of triethylam- 
monium bicarbonate (TEAB). The peak which was 
eluted at 0.9 M TEAB was collected and evapora- 
ted in vacua under argon to dryness. The residue 
was dissolved in water (2 ml), and the solution 
added dropwise to 50 ml 1% NaI acetone solution 
saturated with argon. The yield of sodium MeT4- 
ATP was 50%. 
2.3. The synthesis of A TP-labeled myoglobin 
(Mb-A TP) 
This was started with human myoglobin (Mb) 
purified as in [7]: 0.25 mg Mb was dissolved in 
100 ~1 sodium borate (pH 10); 2 ~1 ATMP solution 
(section 2.1) was added. The mixture was kept for 
30 min at 37°C and subjected to gel-filtration on 
Sephadex G-50 in 0.1 M phosphate (pH 7.5). The 
polymer peak was collected, divided into 100 pl ali- 
quots and kept at - 10°C. 
2.4. ATP-metric immunoanalysis for thyroxine 
Rabbit anti-T4 serum (a gift of Dr T. Loevgren, 
LKB, Wallac, Turku) was bound with 
BrCN-Sepharose (Pharmacia, Uppsala): 1 mg im- 
munoadsorbent was suspended in buffer A 
(0.01 M sodium borate (pH 8.4)-0.15 M 
NaCl-I % bovine serum albumin); 2.6 x 
lo-” mol (40 ng) MeT4-ATP in buffer A (400~1) 
was added to 200 ~1 immunoadsorbent suspension 
(5 mg/ml) followed by 200~1 T4 standard, or 
unknown human serum, and 2 ml 0.01 M sodium 
borate (pH 8.4). The mixture was shaken for 12 h 
at 37°C and centrifuged at 0°C. The supernatant 
was thoroughly removed. The adsorbent was 
suspended in 200~10.01 M HCl, kept for 90 min 
at 37°C and centrifuged; 1OOJ supernatant was 
mixed with 700 pl 0.1 M Tris-acetate (pH 
7.8)-2.8 mM EDTA. The concentration of ATP 
was determined in the solution obtained using the 
ATP-monitoring luciferin-luciferase kit no.2 and 
Luminometer 1250 of LKB Produkter AB 
(Sweden) according to the manufacturer’s instruc- 
tions; 2.6 x lo-” mol ATP gave a signal of 
200 mV. The signal was directly proportional to 
the concentration of ATP over a wide range. 
2.5. ATP-metric immunoanalysis for myoglobin 
Rabbit anti-Mb serum was immobilized by UV- 
irradiation on 9 mm photoreactive paper discs (the 
preparation of these azido-group-containing discs 
will be described elsewhere). Antibodies im- 
mobilized on a single disc bound about 4 ng Mb. 
Wet discs were placed into test-tubes, and 0.6 x 
lo-l2 mol (10 ng) Mb-ATP in 100~1 buffer B 
[0.05 M sodium phosphate (pH 7.5)-0.08 M 
NaCI-0.01 M EDTA-0.5% bovine serum 
albumin] followed by 100~1 standard or sample 
were added. The standards were prepared in the 
following buffer: 0.05 M sodium phosphate (pH 
7.5)-0.08 M NaCl-0.01 M EDTA-4% bovine 
serum albumin- 1% bovine serum im- 
munoglobulin G. Over 6 h gentle shaking at 25°C 
the reaction mixture was removed by suction, and 
the disks washed with 500~1 0.05 M sodium 
phosphate (pH 7.5)-0.08 M NaCl-0.01 M 
EDTA-0.2% Twin 20, followed by 1 ml water: 
The discs were placed into 0.02 M HCl (100~1) 
and incubated for 75 min at 40°C in closed test- 
tubes. After the hydrolysis, 700 ,ul 0.1 M 
Tris-acetate (pH 7.8)-2.8 mM EDTA was added, 
and the mixture incubated during 30 min at 37°C; 
200~1 ATP-monitoring mixture [2] was added, 
and the level of light emission was measured by 
means of Luminometer 1250. 
2.6. Radioimmunoanalysis 
Radioimmunoanalysis for T4 and the measure- 
ment of the antigenic activity of MeT4 were per- 
formed using the T4-RIA kit of Farmos 
Diagnostica (Turku) according to the manufac- 
turer’s instructions. Radioimmunoanalysis for Mb 
has been described [7]. 
3. RESULTS 
It is known that adenosine-5 ’ -trimetaphosphate 
reacts with amines to give ATP y-amidates [5]: 
Scheme 1 
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Table 1 
Stoichiometry of the labelling of Mb by ATP 
Mb-ATP dilution [Mb] as deter- [ATP] determined 
after gel mined by RIA by luminometry 
filtration after acidic 
hydrolysis 
1:2ooo 9.8 nM 52 nM 
1:4000 5.6 nM 25 nM 
We used this reaction to attach the ATP label to 
antigens. Regeneration of free ATP was perform- 
ed by mild acidic treatment which cleaves the 
phosphoamide bond in ATP y-amidates 151. 
The structure of MeT4-ATP obtained follows 
from: (i) the method of its synthesis which is 
known to give ATP y-amidates [5]; (ii) UV- 
spectroscopy; (iii) quantitative transformation into 
MeT4 and ATP under mild acidic treatment; (iv) 
immunological properties described below. 
ATMP reacts with Lys and His residues in pro- 
teins. Modification of Mb under the conditions in 
section 2 afforded a product which contained 5 - 
pppA residues/molecule of immunoIogicaIIy active 
B/T - 
% 
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Fig. 1. Comparison of the immunological properties of 
“‘I- and ATP-labelled antigens: (A) Displacement of
rZfI-Td from an immune complex by T4 (0) and by 
MeT4-ATP (a); (B) displacement of ‘251-Mb from an 
immune complex by Mb (A) and by Mb-ATP (A). The 
data were obtained by the RIA procedure where either 
Mb and T4, or Mb-ATP and MeT4-ATP were taken as 
‘standards’: abscissae, concentrations of displacing 
reagents in samples; ordinates, ratios of the amounts of 
bound radioactive antigens to the amounts of 
radioactive antigens in reaction mixtures, B/T (@lo). 
0 80 160 240 T~,ntp'ml 
Fig.2. ATP-metric immunoassay of normal sera for T4: 
(0) standard curve; (0) sera of normal donors; (---I 
borderlines of normal T4 concentration. 
protein (table 1). Modified Mb is stable. No loss of 
-pppA residues or of the immunological activity 
was observed in one year of storage at -4°C. 
The antigenic properties of MeT4 and Mb were 
not changed significantly after the ‘labelling’ with 
ATP (fig. 1). Fig.2 shows a standard curve and the 
results of ATP-metric determination of T4 in a few 
normal human sera; the curve meets the usual 
criteria of immunoanalysis; T4 concentrations 
found are within the normal range. 
Fig.3 shows a standard curve for ATP-metric 
determination of Mb. With this antigen, direct 
comparison was made of the ATP-metric assay 
and the homogeneous assay and the homogeneous 
RIA method. A good correlation was obtained 
(r = 0.94). However, the ATP-metric procedure, 
mV 
_I 
ml 
Fig.3. A typical standard curve for solid-phase ATP- 
metric immunoanalysis for Mb; abscissa, concentration 
of Mb in sample. 
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DILUTION 
Fig.4. Concentrations of Mb found by ATP-metric 
immunoanalysis for several dilutions of a human serum 
with a high content of Mb. 
compared with RIA, gave a systematic increase in 
the concentration of Mb found (Y = 1.7 x + 31). 
The reason for this discrepancy has not been 
studied, but it is known that solid-phase pro- 
cedures sometimes give higher values, compared 
with homogeneous procedures [8]. It is interesting 
that the non-specific adsorption in the ATP-metric 
procedure for Mb (fig.3) is zero. The repeatability 
of the procedure is also satisfactory, the mean 
square deviation value (a) was + lo%, as 
calculated from the data of 20 analyses of a single 
serum (Mb = 28.4 ng/ml). Dilution of a serum 
with a high content of Mb revealed a linear 
dependence of the dilution coefficient over Mb 
50-500 ng/ml (fig.4). However, the ATP-metric 
procedure, as well as the standard RIA-procedure 
0 
a 16 2L h 
Fig.5. Dynamics of concentrations of Mb in sera of 
patients with myocardial infarction (a,~) and unstable 
myocardia (A, A) found by the RIA-procedure (@,A) 
and by ATP-metric immunoanalysis (0, A). 
(review [7]), reveals characteristic dynamics of Mb 
concentrations in sera of patients with myocardial 
infarction and unstable stenocardia (fig.5); it af- 
fords valuable diagnostic information. 
4. DISCUSSION 
The above data illustrate the validity and the 
general applicability of the novel ATP-metric im- 
munoanalytical system proposed. The advantages 
of the procedure, compared with other techniques 
are: (i) the high stability of the ATP label; (ii) the 
simplicity of its coupling to antigens; (iii) the high 
sensitivity of the luminometric procedure; (iv) 
simplicity of the measuring equipment. 
The bioluminescent test with luciferase is not the 
only ultrosensitive method for ATP detectiorl. 
Cyclic multi-enzyme systems may be designed in 
which ATP acts as a catalyst [9]; these systems may 
use spectrophotometry as the final detection 
method. 
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